Get the Stockscreener App
5.59
0.18%
-0.010
Clinuvel Pharmaceuticals Limited American Depositary Shares stock is traded at $5.59, with a volume of 1,622.
It is down -0.18% in the last 24 hours and down -6.05% over the past month.
See More
Previous Close:
$5.60
Open:
$5.56
24h Volume:
1,622
Relative Volume:
0.25
Market Cap:
$282.22M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-2.61%
1M Performance:
-6.05%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$5.525
$5.80
52-Week Range:
$5.525
$8.20
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Company Profile
Name
Clinuvel Pharmaceuticals Limited American Depositary Shares
Sector
Industry
Phone
-
Address
-
Compare CUVL vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CUVL
Clinuvel Pharmaceuticals Limited American Depositary Shares
|
5.59 | 282.22M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Latest News
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - markets.businessinsider.com
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - GlobeNewswire
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion - The Manila Times
Clinuvel Pharmaceuticals (ASX:CUV) Releases FY26 Report After Expanding U.S. Market Access - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV): US Expansion Strategy and Nasdaq Listing Transition - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Makes U.S. Pivot With Nasdaq Uplisting and Headquarters Shift Plan - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Greater US Exposure Trigger a Powerful New Growth Chapter? - Kalkine
Clinuvel Pharmaceuticals (CUVL) uplifts ADR to Level II ADS - Stock Titan
CLINUVEL Pharmaceuticals Completes Nasdaq Uplift with ADS Trading Launch Under CUVL Ticker - Kalkine
Clinuvel Pharmaceuticals (ASX:CUV) Lands on Nasdaq—Could Its New US Listing Transform Global Investor Interest? - Kalkine
CLINUVEL’s ADS to commence trading on Nasdaq - globenewswire.com
CLINUVEL Pharmaceuticals Launches American Depositary Shares on Nasdaq Global Select Market - Kalkine
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
IPO Calendar for: - Yahoo! Finance Canada
CLINUVEL’s ADS to commence trading on Nasdaq - Yahoo Finance
CLINUVEL expects Nasdaq trading; no new shares proposed - Stock Titan
CLINUVEL ADS to commence trading on Nasdaq - scanx.trade
Clinuvel (ASX:CUV) Eyes Nasdaq: What the 20-F Filing Means for CUV Shareholders - Kalkine
CLVLY SEC FilingsClinuvel Pharmaceuticals Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Clinuvl Phrmaceu (CLVLY) Stock Price, News & Analysis - Stock Titan
Clinuvel Pharmaceuticals Limited American Depositary Shares Stock (CUVL) Financials Data
There is no financial data for Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.64%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):